aligos.com

Aligos Therapeutics

Aligos Therapeutics's email is info@aligos.com .

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particul...

read more

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.

show less

View Top Employees for Aligos Therapeutics
img Website aligos.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 66
img Founded 2018
img HQ 1 Corporate Dr., 2nd Floor
img Email info@aligos.com
img Funding 308,600,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website aligos.com
img Industry Biotechnology
img Location South San Francisco, California, United States
img Employees 66
img Founded 2018
img LinkedIn linkedin.com/company/aligos-therapeutics
img HQ 1 Corporate Dr., 2nd Floor
img Email info@aligos.com
img Funding 308,600,000 USD